Status:
COMPLETED
Metabolic Effects of Olanzapine in Healthy Males
Lead Sponsor:
State University of New York at Buffalo
Conditions:
Healthy
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
The purpose of this study is to look at how a two-week use of a medication called Olanzapine might change appetite, physical activity, resting metabolic rate, body composition, and weight in healthy m...
Eligibility Criteria
Inclusion
- Healthy Volunteer
- Male
- Aged 18-35 years
- Body Mass Index (BMI): \<30 kg/m2
Exclusion
- Presence of any medical disorder that may confound the assessment of relevant biological measures
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01496183
Start Date
October 1 2007
End Date
April 1 2013
Last Update
August 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, The State University of New York at Buffalo
Buffalo, New York, United States, 14215